complexity to the treatment of VGAMs. 13 Our aim was to determine whether there is an association with bony remodeling of the jugular foramina.
Methods

Patient Population
Data were extracted from a single-center database of The Hospital for Sick Children. Thirty-five consecutive cases involving children presenting with a true VGAM between January 2007 and June 2014 were identified. From this cohort, those patients with severe jugular stenosis were studied, as in our department all patients with a VGAM who present with severe JBS undergo a CT scan to assess the size of the jugular foramina in case endovascular treatment of the stenosis was required. If no significant JBS was noted in the follow-up imaging studies (MRI or digital subtraction angiography), no CT scan was indicated and noninvasive imaging follow-up was performed with MRI and MR angiography (MRA) only. Thus there was no CT assessment of the size of the jugular foramina in the population without severe JBS, so bony foraminal changes could not be analyzed in those patients.
clinical Features
The following data were collated for each patient: sex, type of vein of Galen (i.e., choroidal or mural), and Bicêtre Outcome Score (BOS) 9, 10 assessed at the last clinical assessment.
radiological Features
Conventional MRI and CT scans performed at birth when available, between 4 and 6 months, and between 12 and 24 months, were reviewed.
The percentage of JBS was assessed on MRA (2D time-of-flight [TOF] sequence) as the smallest diameter of the jugular bulb on a sagittal/lateral view over the diameter of the jugular vein 2 cm below the jugular foramina (Fig. 1) . As there is no consensus regarding what percentage stenosis equates to clinical significance, we used a previously published threshold value of 70%. 6 We only determined a stenosis of greater than 70% to be significant if there was involvement of the bilateral jugular bulbs. The values for the measurements of the jugular bulbs are presented as the mean of the stenosis on both sides, with the individual measurements for the right and left presented in parentheses.
The diameter of the jugular foramina was measured on sagittal CT imaging, on a slice passing at the level of the jugular vein. We also compared the jugular foramina diameters to measurements obtained in a matched population of 20 patients of the same age groups (i.e., 20 patients between 4 and 6 months old and 20 patients between 1 and 2 years old) who had no VGAM and had undergone cerebral CT for a reason other than vascular disease.
statistical analysis
Descriptive statistics were calculated to summarize the distribution of JBS or narrowing of the jugular foramina at 4-6 months and 1-2 years of age (Table 1 ). The distribution of categorical variables was described by frequencies and percentages; the distribution of continuous and non-normally distributed variables was described by medians and interquartile ranges (IQRs). Univariate statistics were performed to assess for associations between jugular foramen narrowing and VGAMs at 4-6 months and 1-2 years of age. These were performed via Wilcoxon-MannWhitney test. A p value < 0.05 was considered statistically significant.
ethical issues
This medical chart and imaging review was conducted after approval by our local research and ethics board. This was a retrospective noninterventional study. No blood tests or clinical investigations were required beyond those required for the standard care of these patients. The study was performed in accordance with our ethical guidelines. 
results
Of the 35 children, 8 had bilateral jugular bulb narrowing, and these patients were included in this series. The median duration of clinical follow-up was 2.5 years (IQR 1.7-4.2 years). Six (75%) of the patients were male and 2 (25%) were female.
The patients' median age at initial presentation was 3.6 months (IQR 1.7-4.8 months). Only 2 patients (Cases 1 and 5) had imaging studies performed in the 1st month of life (Day 1 for both), and no JBS was observed in those studies. The patients' median age at 4-6 months imaging was 4.8 months (IQR 4.4-5.3 months). Only 4 patients had bilateral significant JBS on these imaging studies (median percentage of stenosis: 92% [IQR 89.5%-94.5%]). The 4 remaining patients had no stenosis (3 patients) or mild stenosis (1 patient had 85% stenosis on the right side and 50% on the left side). In the cases of bilateral JBS, the stenosis was identified when the patients were between 1 and 2 years of life (median 14.7 months [IQR 13.4-16 months]) with a median stenosis of 96% (IQR 77%-100%).
JBS was associated with bony narrowing of the jugular foramina in 7 of the 8 patients over time. In these 7 patients, the median diameter of the jugular foramina was 3.4 mm (IQR 2.4-4 mm) at 4-6 months of age and 3 mm (IQR 2.4-3.9 mm) at 1-2 years of age (Fig. 1) . In the patient who did not demonstrate narrowing of the jugular foramina, the diameters of the foramina were 3.6 mm bilaterally at 6 months of age and 7 mm at 1.2 years of age despite no improvement in JBS.
In the matched controls, the mean diameter of jugular foramina was 3.9 mm (IQR 3.3-4.2 mm) at 4-6 months and 5.1 mm (IQR 4.4-5.6 mm) at 1-2 years. At 4-6 months there was no significant difference between the mean diameter in our population and the matched population. However, in the studies obtained when the patients were 1-2 years of age, the jugular foramina were significantly narrower in patients with a VGAM than in the matched controls (p = 0.015).
The patients' median age at the last clinical follow-up was 2.5 years (IQR 1.7-4.2 years), and the BOS was 1 in 1 patient, 2 in 2 patients, 4 in 3 patients, and 5 in 2 patients.
The main findings are summarized in Tables 1-3 .
Discussion
The cause of the jugular bulb stenosis or occlusion is unknown. The influence of abnormal skull base growth maturation caused by macrocrania as opposed to a venous high-flow angiopathy has been hypothesized. 9, 14 In the present series, we were not able to assess whether the jugular bulb was narrowing prior to the jugular foramen. However, we observed 1 patient (Case 2) without bony narrowing and 2 patients (Cases 1 and 5) with no or limited bony narrowing on one side despite severe JBS. Thus, we hypothesize based on these limited observations that venous high-flow angiopathy seems to precede the bony foraminal narrowing. The bony narrowing may thus be a secondary phenomenon following the decreased jugular bulb diameter but may be absent in rare cases (only 1 patient in the present series).
We did not find any angiomorphological features that could be used to predict jugular foramen stenosis when comparing the current group to the remainder of VGAM patients who did not present with JBS. If the JBS is severe, the VGAM and the brain may drain into the same cavernous sinus outlets. Thus some degree of cerebral pial congestion may exist without reflux. 9 The long-term result is a chronic ischemic phenomenon with delayed calcifications and the peculiar "pseudo-phlebitic" appearance of the cortical veins. This condition can lead to a very poor outcome, and may even appear if the vein of Galen arteriovenous shunt is completely cured. This is illustrated in the case reported by Brew et al., in which a patient with a VGAM that was successfully treated with complete embolization of the shunt died 1 year after treatment following total occlusion of the jugular bulbs in the absence of alternative venous outflow pathways. 3 In our experience, we have also had a patient with a VGAM in Bicêtre (not reported) with bilateral jugular bulb occlusion who, despite complete occlusion of the VGAM shunts, experienced delayed hydrovenous complications, including hydrocephalus requiring shunting as well as cerebral venous thrombosis. This patient subsequently died of these complications 2 years following jugular bulb occlusion.
Our series demonstrated that JBS is associated with narrowing of the jugular foramina in most cases. This may have implications for treatment. There is currently only 1 article reporting angioplasty of the jugular vein in VGAM, 3 but this treatment may be considered as a therapeutic option as JBS precedes the bony changes. Prior to any such treatment, we recommend evaluation for bony stenosis, as bony constriction may hinder successful dilation of the vessel. If bony changes are, however, only occurring secondarily after initial venous stenosis, angioplasty may be warranted to avoid secondary irreversible bony changes. In the presence of bony stenosis a bypass may be considered as an alternative therapy.
JBS was not seen at birth in our limited series, as previously reported.
14 The 2 patients with early imaging (1st day of life) had no evidence of JBS. Stenoses seemingly develop later, during the first months of life. JBS was not only associated with high-flow fistulas, as in our cohort 3 patients presented with a slow-flow choroidal VGAM and 5 patients with high-flow shunts. Additionally, at 4-6 months of age, there was no predominance of stenosis in the patients with high-flow VGAMs compared with those with slow-flow lesions.
This study has the inherent limitations of a retrospective study. Moreover, given the small size of the population, we are unable to draw any firm conclusions regarding the nature and exact timing of JBS. However, we believe that this small observational study demonstrates some potentially clinically relevant and pertinent findings with therapeutic implications.
conclusions
In case of JBS or occlusion in VGAM, a CT scan should be performed to identify whether there is any associated bony narrowing. JBS or occlusion in VGAM seems to have a male predominance. Mechanisms are still poorly understood, and our study did not identify any angiomorphological features of VGAMs that predicted occurrence of this complication. In cases in which treatment is required, bony narrowing of the jugular foramina should be taken into account when deciding whether angioplasty and stenting or surgical bypass might be appropriate therapeutic options. 
